共 50 条
- [1] Efficacy and Safety of VTD-PACE Regimen in Relapsed or Refractory Multiple Myeloma [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E57 - E57
- [3] Bendamustine in heavily pre-treated patients with relapsed or refractory multiple myeloma [J]. Journal of Cancer Research and Clinical Oncology, 2015, 141 : 2205 - 2212
- [5] Real-world clinical outcomes in patients with relapsed and refractory multiple myeloma receiving VTD-PACE treatment in the era of monoclonal antibodies [J]. Annals of Hematology, 2023, 102 : 3489 - 3497
- [8] VTd-PACE and VTd-PACE-like regimens are effective salvage therapies in difficult-to-treat relapsed/refractory multiple myeloma: a single-center experience [J]. Annals of Hematology, 2023, 102 : 117 - 124